A Novel In Vivo Method Using <i>Caenorhabditis elegans</i> to Evaluate α-Glucosidase Inhibition by Natural Products for Type 2 Diabetes Treatment
Background: Non-insulin-dependent diabetes mellitus, or type 2 diabetes, is one of the diseases of greatest concern worldwide, and research into natural compounds that are capable of regulating glycemia and insulin resistance is therefore gaining importance. In the preclinical stages, <i>Caenorhabdi...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2024-12-01
|
| Col·lecció: | Pharmaceuticals |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1424-8247/17/12/1685 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|